MedPath

A study to evaluate the efficacy of L-carnitine injection in dialysis patients with complications

Not Applicable
Conditions
chronic kidney disease
Registration Number
JPRN-UMIN000011313
Lead Sponsor
Showa University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Patients known to have a history or complication of allergy to L-carnitine. Women who are pregnant or possibly pregnant. Patients who are judged to be inappropriate to this study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
sage dose of ESA
Secondary Outcome Measures
NameTimeMethod
serum carnitine concentration, QOL, muscle symptoms, inflammatory marker, nutritional status, cardiothoracic ratio, adverse events
© Copyright 2025. All Rights Reserved by MedPath